Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-26-002834

Chief Accounting Officer acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lerner Neil Chief Accounting Officer 2026-04-29 Grant or award +15,000 $1.89 $28,350 397,500 D
Loading xslF345X06/ownership.xml…